AI Science Tracker
EN

Department of Blood Transfusion, The Third Xiangya Hospital of Central South University, Changsha, China

1 discovery from 2021

Discoveries

A Novel Intercellular Communication-Associated Gene Signature for Prognostic Prediction and Clinical Value in Patients With Lung Adenocarcinoma

Source check: Source checked. Not independent scientific confirmation.

Finding: Multi-dataset machine-learning and intercellular-communication analysis identified lung-adenocarcinoma genes associated with prognosis and immune-cell signaling; these remain candidate associations.

Technology: The original Methods describe the learning operation and Results connect it to the specific disease or outcome finding.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The original Methods describe the learning operation and Results connect it to the specific disease or outcome finding.
Test and result
Full-text Results were examined for outcome, data/cohort and scope.
Limitation / still unknown
Reported comparison, experimental confirmation or held-out evaluation was checked; reason limits interpretation to the evidence.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fgene.2021.702424 · https://europepmc.org/article/MED/34497634 · https://europepmc.org/articles/PMC8419521 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8419521/unicode · https://pubmed.ncbi.nlm.nih.gov/34497634/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.